Cargando…
Ethical challenges with the left ventricular assist device as a destination therapy
The left ventricular assist device was originally designed to be surgically implanted as a bridge to transplantation for patients with chronic end-stage heart failure. On the basis of the REMATCH trial, the US Food and Drug Administration and the US Centers for Medicare & Medicaid Services appro...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527574/ https://www.ncbi.nlm.nih.gov/pubmed/18694496 http://dx.doi.org/10.1186/1747-5341-3-20 |